Clinical Validation of a Volumetric Absorptive Micro-Sampling Device for Pharmacokinetic Studies With Tranexamic Acid (2021)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.764379
PubMed Identifier: 34887763
Publication URI: http://europepmc.org/abstract/MED/34887763
Type: Journal Article/Review
Parent Publication: Frontiers in Pharmacology
ISSN: 1663-9812